Administration of semaglutide before metabolic and bariatric surgery does not confer benefits for overall weight loss, ...

A study by Mass General Brigham found that taking the weight-loss drug semaglutide before bariatric surgery does not lead to ...

But the newest study that has gone viral is an even more impressive outcome. Headlines are claiming that researchers have ...

Mass General Brigham researchers found that total weight loss did not increase for patients who took semaglutide before ...

Hims & Hers Health (NYSE: HIMS) has been a top healthcare stock to own over the past five years, soaring by around 350% ...

While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that ...

HFpEF outcomes were improved with semaglutide, compared with placebo, among patients with obesity-related HFpEF and type 2 diabetes.

Stanford researchers have discovered BRP, a naturally occurring peptide that suppresses appetite and promotes weight loss, ...

Stanford Medicine researchers have identified a naturally occurring molecule that mimics the appetite-suppressing effects of ...

For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION).

After screening 20,000 protein-encoding genes in the human body, Stanford researchers have identified a naturally occurring ...